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INTRODUCTION 
Adenylosuccinate synthetase [IMP-L-aspartate ligase (GDP), EC 6.3.4.4] 
is an enzyme involved in the de novo biosynthesis of purines and catalyzes 
the reaction shown below: 
H C^^COOH 
0 N H COOH 
+ Aspartate + GTP 
Ri bose-phosphate Ri bose-phosphate 
IMP Adenylosuccinate 
Purines are synthesized de novo by most organisms and the details of 
their biosynthesis have been determined by Buchanan and Greenberg and their 
coworkers (Buchanan and Sonne, 1946; Buchanan et at., 1948; Sonne et aZ., 
1946, 1948; Greenberg, 1948, 1951; Goldthwait et al. ^ 1954; Greenberg and 
Jalniche, 1957). The various steps involved in their biosynthesis have 
been reviewed by Buchanan and Hartman (1959) and Balis (1968). 
The synthesis of AMP from IMP and aspartate was first shown by Abrams 
and Bentley (1955) in rabbit bone marrow and by Lieberman (1956) in 
Esoheviahia ooli. Carter and Cohen (1955, 1956) have shown that adenylo­
succinate is an intermediate in the synthesis of AMP. Lieberman (1956) 
demonstrated adenylosuccinate could be reversibly formed from IMP and 
aspartate by a partially purified protein fraction from e. oolit and he 
suggested from ^^0 incorporation studies that 6-phosphoryl-IMP was an 
intermediate in the reaction. From equilibrium-exchange studies of the 
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reaction, Fromm (1958) also suggested that 6-phosphoryl-IMP could be an 
intermediate. Miller and Buchanan (1962) studied the arsenolysis of 
adenylosuccinate and concluded from the absolute requirement for GDP that 
the mechanism involved a stepwise arrangement of all the substrates on the 
enzyme surface preceding product formation. No further studies have been 
made on the mechanism of the reaction. 
Wyngaarden and Greenland (1953) have investigated the inhibition of 
the enzyme by nucleotides. AMP, adenylosuccinate, GMP, and GDP were shown 
to be effective inhibitors of the reaction. They suggested that AMP and 
GDP might function in vivo to control AMP biosynthesis. 
Most recent studies on the enzyme have involved investigation of the 
structural requirements for binding at the IMP and aspartate sites on the 
enzyme. Baker (1967) has suggested that the ribose-phosphate moiety of IMP 
is most important for its binding. A large number of studies on substitu­
tions in the ribose-phosphate moiety have been made by Baker and Hampton 
and their coworkers (Baker and Tanna, 1963, 1965a, b, c; Nichol et al. ^ 
1967; Hampton and Chu, 1970). The major conclusion of these investigations 
is that although a purine moiety is required for binding at the IMP site, 
the phosphate group and the ribofuranose ring determine how well an 
analogue of IMP will bind to the enzyme. 
The naturally occurring antibiotic hadacidin (N-formyl-N-hydroxyamino 
acetic acid), which blocks de novo purine synthesis, has been shown by 
Shigeura and Gordon (1962a, b) to strongly inhibit adenylosuccinate 
synthetase by competitively binding at the aspartate site with an apparent 
inhibition constant of 4.2 x 10"^ M as compared to the Michaelis constant 
of 1.5 X lor^ M for aspartate. 
3 
The purpose of this study was to develop a better procedure for the 
purification of adenylosuccinate synthetase from E. aoli B and to study the 
kinetic mechanism of the reaction catalyzed by the enzyme. 
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EXPERIMENTAL PROCEDURE 
Materials 
E. oolii Strain B, cells, which had been grown on an enriched medium 
based on a casein hydrolysate and harvested at the three-fourths log stage, 
were obtained from Grain Processing Company, Muscatine, Iowa. GTP, GDP, 
IMP, streptomycin sulfate, 2-mercaptoethanol, HEPES, and L-aspartate were 
obtained from Calbiochem. Adenylosuccinate was synthesized from AMP and 
fumarate as described by Carter and Cohen (1956). 6, y-5'-Guanylylmethylene 
diphosphonate was a product of Miles Laboratories. Thio-IMP was supplied 
by P-L Biochemicals. N,N,N',N'-tetramethylethylenediamine and riboflavin 
were products of Canalco and the acrylamide used was supplied by Eastman 
Organic Chemicals and was recrystallized from chloroform as described by 
Loening (1967). All other chemicals were obtained from commercial sources 
and were reagent grade. 
DEAE cellulose and DEAE cellulose paper (DE-81) were products of 
H. Reeve Angel and Co., Ltd. The cellulose was in the microgranular form 
and was supplied as a wet powder (DE-52). Sephadex G-lOO was supplied by 
Pharmacia Fine Chemicals, Inc. 
Methods 
Standard assay The determination of adenylosuccinate synthetase 
activity during the purification was made by observing the increase in 
absorbance at 280 nm accompanying the conversion IMP to adenylosuccinate. 
The assays were carried out in a 1.0 ml total volume containing 20 mM 
HEPES, pH 7.7, 1 mM MgSO^, 0.6 mM streptomycin sulfate, 5 mM aspartate. 
5 
0-15 mM IMP, and 0.06 mM GTP. The reactions were followed at 28° in a Gary 
model 15 recording spectrophotometer with a thermostatted cell housing 
using an extinction coefficient of 11.7 x 10^ cm^ per mole at 280 nm for 
the formation of adenylosuccinate from IMP (Atkinson et dl. •, 1964). 
Increase in absorbance due to the presence of aspartase in the initial 
steps of the purification was corrected for by using a blank reaction 
mixture minus the nucleotides. One unit of activity is defined as 
molarity of adenylosuccinate formed per minute. 
Protein determination The protein concentration was determined by 
use of the Biuret method (Gornall et al- , 1949) with bovine serum albumin 
as a standard. Concentration is expressed as mg of protein per ml of 
solution. Specific activity is expressed as units of enzyme activity per 
mg of protein. 
Analytical disc gel electrophoresis Purification of the enzyme 
followed by use of analytical disc gel electrophoresis as described by 
Ornstein (1964). A 7.5% acrylamide separating gel was used and a band of 
10% sucrose was layered on top of it. The protein sample was made to 5% 
concentration in sucrose and layered above the 10% band. Electrophoresis 
was carried out at 5° with a current of 2.5 ma per tube (0.5 x 6.0 cm). 
Protein was stained with amido-schwartz dye and the excess dye was washed 
out with 7% acetic acid. The gels were stored in 1% acetic acid. 
Nucleotide concentration and purity Concentrations of the 
nucleotides used in this study were determined from their characteristic 
ultraviolet absorption (P-L Circular OR-10, 1961). The purity of the 
6 
nucleotides was determined by chromatography on DEAE cellulose paper as 
described by Morrison (1968). The ammonium formate buffer solution 
described by Morrison was diluted 5:1 to obtain better resolution. The 
nucleotides were all found to be essentially pure as evidenced by ultra­
violet examination of the chromatograms. 
Stability constant determination In most previous studies on this 
enzyme, glycine at pH 8.0 was used as a buffer for the reaction. Owing to 
its structural similarity to aspartate and its poor buffering capacity at 
this pH, it would appear to be a poor choice as a buffer for this system. 
Since Lieberman (1956) has shown that Tris-Cl is an inhibitor of the 
reaction, one of the buffers described by Good et dl. , (1966), HEPES, was 
chosen. The lack of a primary amino group and its pK of 7.55 make HEPES 
an ideal buffer for this system. 
No data were available on the stability constants of the magnesium 
complexes with various nucleotides in HEPES buffer. Because of the 
necessity of controlling free magnesium concentration in the reaction 
mixture, the stability constants were determined by the method of Burton 
(1959), which involves measuring the spectral differences of 8-hydroxy-
quinoline and its magnesium complex in the presence and in the absence of 
other ligands. The determinations were made with adenyl phosphates, but 
should be valid for all nucleotides since the value of the stability 
constant depends essentially on the phosphate portion of the nucleotide 
(Walaas, 1959). 
Spectral changes at 360 nm were measured on a Gary model 15 spectro­
photometer. Values of MgZ* concentration when Mg-ligand complex 
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concentration equals one-half the total ligand concentration were plotted 
against ligand concentration. Extrapolation to ligand concentration = 0 
gave a value for the stability constant. Values in 20 mM HEPES, pH 7.7, 
28°, were as follows: MgATP?-, 100,000; MgADP', 10,000; and MgAMP, 110 MTi. 
Binding of magnesium to aspartate, succinate. Pi, and streptomycin sulfate 
was also investigated. Aspartate and succinate had stability constants of 
less than 50 M"^ in 20 mM HEPES, while the stability constant with 
streptomycin and Pi was approximately 100 M"^. The stability constant for 
MgATp2" was also determined in 20 mM HEPES, pH 7.7, containing 0.1 M tetra-
ammonium bromide (0'Sullivan and Perrin, 1964), and was found to be 
48,000 M-i. 
In carrying out the kinetic experiments these stability constants were 
used to fix the free magnesium concentration at 1 mM except for the 
experiments involving GDP, where the free magnesium concentration was held 
at 2.5 mM. The percentage of GTP in complex with magnesium was 98% or 
above in all experiments, even at the higher ionic strength used in the 
succinate inhibition experiments. Ninety-six percent of the GDP was in 
form of MgGDpi", while a maximum of 10% of the IMP is present as MgIMP at 
1 mM free magnesium and 20% at 2.5 mM free magnesium. 
Initial rate experiments Initial rate experiments were carried out 
at 28° in the Gary model 15 recording spectrophotometer with a thermostatted 
cell housing, using the 0 to 0.1 absorbance slide wire. The reactions were 
carried out in a volume of 1.0 ml containing 20 mM HEPES, pH 7.7, 0.8 mM 
streptomycin sulfate, either 1.0 or 2.5 mM (in the GDP inhibition experi­
ments only) free magnesium (as magnesium sulfate), sufficient magnesium to 
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complex al 1 ligands at the specific free magnesium concentration, aspartate, 
ATP, and IMP. In the inhibition studies, the given inhibitor and sufficient 
magnesium to complex it were also added. The reaction was initiated by 
addition of enzyme to the reaction mixture that had been incubated at 28° 
for ten minutes. The conversion of IMP to adenylosuccinate was then 
followed continuously at 280 nm for from 3 to 6 minutes. Initial velocity 
was expressed as molarity of adenylosuccinate formed per minute. 
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RESULTS AND DISCUSSION 
Purification of adenylosuccinate synthetase 
Adenylosuccinate synthetase was first purified by Lieberman (1955), 
but the resulting enzyme was not pure and no significant improvements in 
the preparation have been made since then. The first three steps described 
here are essentially the same as used by Lieberman, but the steps following 
the low pH treatment were worked out during this study. 
E. ooli B cells, which were supplied as a frozen paste, were thawed 
and suspended in a volume in ml of cold 5 mM KPi buffer, pH 7.0, equal to 
the weight of the frozen cells in grams. The suspension was passed through 
a French pressure cell which had been precooled to 5°. This and all 
subsequent steps are carried out at 5° unless otherwise noted. The pressure 
in the cell was maintained at 20,000 psi during cell lysis. The ruptured 
cells were diluted to a volume approximately equal to three times the wet 
weight of cells used in grams, and then centrifuged at 16,000 x g for 15 
minutes. The cellular debris was discarded and the supernatant cell free 
extract was treated immediately. 
Ten ml of a 11% solution of streptomycin sulfate solution for each 100 
ml of cell free extract was added slowly with stirring to the cell free 
extract. After 10 minutes the solution was centrifuged at 16,000 x g for 
20 minutes to remove the precipitate. The supernatant streptomycin fraction 
was then immediately adjusted to pH 5.4 with 0.1 M acetic acid with constant 
stirring. The solution was then placed in a 37° constant temperature bath 
and maintained at 37° for 15 minutes with constant stirring. It was then 
cooled in an ice bath, and the milky precipitate was removed by 
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centrifugation at 16,000 x g for 15 minutes. The pH of the low pH fraction 
was then adjusted to 6.8 with 1 M KOH. 
Forty-five grams of ammonium sulfate for each 100 ml of the low pH 
fraction was then slowly added with stirring. After 15 minutes the 
precipitate was collected by centrifugation at 16,000 x g for 20 minutes. 
The supernatant was discarded and the precipitate was dissolved in 0.08 M 
KPi buffer, pH 7.0, containing 5 mM 2-mercaptoethanol and 1 mM EDTA. In 
the following steps the term buffer will refer to the specified concentra­
tion of KPi at pH 7.0 containing 5 mM 2-mercaptoethanol and 1 mM EDTA. The 
dissolved ammonium sulfate fraction was then dialyzed against 0.05 M buffer. 
DEAE was prepared by washing with 0.5 N HCl followed by 0.5 N NaOH and 
then converted to the phosphate form by equilibrating with 1 M phosphate 
followed by extensive washing with water. The resin was then equilibrated 
by stirring with 0.08 M buffer. A column was poured with the equilibrated 
DEAE and several volumes of 0.08 M buffer were washed through. The 
dialyzed ammonium sulfate fraction was washed onto the column at a concen­
tration of 100 mg of protein per 10 ml of column volume, and the column was 
washed with the 0.08 M buffer until the 280 nm absorbance of the effluent 
was less than 0.05. A linear gradient between 0.08 and 0.20 M buffer was 
then used to elute the enzyme. The total volume of the gradient was 
approximately ten times the column bed volume. 
The column effluent was collected in a refrigerated fraction collector 
using a drop counter and 15 ml volumes were collected. The fractions were 
assayed for activity as described under "Methods" and the active fractions 
were pooled and concentrated by dialysis against a ten-fold excess of 
saturated ammonium sulfate containing 0.10 M buffer. The precipitated 
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protein was collected by centrifugation at 16,000 x g for 15 minutes and 
then dissolved in a minimal volume of 0,10 M buffer. 
A'Sephadex G-1ÛÛ column (2.5 x 100 cm) was prepared and equilibrated 
with 0.10 M buffer. The concentrated protein solution from the DEAE step 
was applied to the column. Two ml fractions were collected in a refrig­
erated fraction collector and the active fractions were pooled and concen­
trated as described for the DEAE step. The precipitated enzyme was 
dissolved in Tris-Cl buffer, 0.37 M, pH 8.0, containing 2 mM N,N,N',N'-
tetramethylethylenediami ne, 5 mM 2-mercaptoethanol, and 1 mM EDTA and then 
dialyzed against several changes of this buffer to remove the ammonium ions. 
The final step in the purification involves the use of a Canalco 
preparative disc gel electrophoresis apparatus. The standard high pH gel 
formulations recommended in the Prep-Disc Instruction Manual were used. 
A 10% acrylamide separating gel (4 cm in height) and 3.5% spacer gel 
(2 cm in height) were used and the protein sample (50 to 100 mg/run) was 
layered on top of the spacer gel under the electrode buffer. Bromophenol 
blue was added to the sample as a tracking dye. The only change from the 
recommended buffer systems involved the addition of 5 mM 2-mercaptoethanol 
and 1 mM EDTA to the elution buffer. 
During the initial part of the electrophoresis, the current was 
maintained at 2.5 ma and then was increased to 5 ma after the protein had 
entered the gel. Elution buffer was pumped through the apparatus at a rate 
of from 10 to 30 ml per hour, depending on the stage of separation. The 
higher flow rate was established after the tracking dye had eluted from the 
gel. The eluent was collected in a refrigerated fraction collector and the 
fractions with the highest enzymic activity were pooled. An analytical 
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disc gel of the enzyme after preparative disc gel electrophoresis along 
with a densitometer scan of the gel is shown in Figure 1. About 90% of 
the protein appears to be in the larger band. The densitometer tracing 
doesn't show the true ratio of concentrations since the larger peak is 
considerably compressed relative to the smaller one. 
The results of a typical preparation are shown in Table 1. A 150-fold 
Table 1. Purification of adenylosuccinate synthetase 
Enzyme fraction Volume Protein Specific 
activity 
Relative 
purificati on 
ml mg/ml units/mg 
Cell free extract^ HOC 35.0 0.58 1 
Streptomycin step 1150 34.0 1.01 1.75 
Low pH fraction 1100 22.0 5.7 9.80 
Ammonium sulfate 
precipitate 400 54.5 12.4 21.4 
DEAE fraction 1900 2.0 52.5 90.5 
Sephadex fraction 200 1.8 89.0 153 
^Based on 390 grams of E. ooll B frozen cells. 
purification is obtained through the Sephadex step. A 3-4 fold purifi­
cation occurs upon preparative electrophoresis but large amounts of enzyme 
have not been carried through this step in the procedure. The inclusion of 
2-mercaptoethanol and EDTA in the buffers used in the purification was found 
to prevent loss of activity. Without these compounds present, a very low 
recovery of enzyme occurs after the column steps. 
13 
# 
ui 
UJ (_) 
> 2 
PS 
< CE 
O 
UJ to 
a: m 
< 
\ 
(-) ELECTRODE ( + ) ELECTRODE 
Figure 1. A photograph of an analytical disc gel of a purified 
adenylosuccinate synthetase preparation along with a 
densitometer tracing of the gel 
Migration of the protein was toward the (+) electrode and 
the gel was stained for protein with amido-schwartz dye. 
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The purification described by Lieberman (1956) gives a 65-fold purifi­
cation, but the assay is based on a stopped time assay which may give low 
values for the enzyme activity in the early steps of the purification due 
to the presence of adenylosuccinase. This would increase the apparent 
purification seen in that procedure. No direct comparisons can be made 
between the two procedures since different conditions are used for 
determination of specific activity. 
•Molecular weight of adenylosuccinate synthetase 
The molecular weight of the enzyme was estimated by use of a Sephadex 
G-lOO column (2.5 x 100 cm) as described by Andrews (1954), The column was 
calibrated with various proteins of known molecular weight as described 
previously (Rudolph and From, 1970). The molecular weight was determined 
to be approximately 56,000 from the data shown in Figure 2, which is a plot 
of elution volume (tube number) versus the log of the molecular weight. 
Initial velocity experiments 
It is clear from a cursory examination of the literature that few 
attempts have been made to study the kinetics of three-substrate enzyme 
systems. It had been suggested (Fromm, 1967) that such systems may be 
segregated into two types (sequential and ping-pong) from initial rate 
studies. A choice may finally be made from among the various mechanisms 
In the two basic classes of enzyme and substrate interactions by using 
competitive Inhibitors as well as product Inhibitors, 
Two basic experimental kinetic protocols may be used to investigate 
a three-substrate enzyme mechanism. In the procedure used by Frieden 
(1959) in studies on glutamate dehydrogenase, one substrate was held at a 
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Figure 2. A plot of elution volume (tube number) versus the log of the 
molecular weight for various standard proteins and adenylo­
succinate synthetase 
The column (Sephadex G-lOO, 2.5 x 100 cm.) was calibrated with 
5 mg of each of the standard proteins shown. They were applied 
in a 1 ml volume containing 5% sucrose and eluted with 0.1 M 
Tris-Cl buffer containing 5 mM 2-mercaptoethanol and 1 mM EDTA. 
Ten mg of adenylosuccinate synthetase was applied to the column. 
16 
constant level while the other two substrates were varied» as in a two-
substrate system. 
In the studies reported below, a procedure outlined previously (Fromm, 
1967) was used. This experimental protocol has been used in this labora­
tory in studies on Coenzyme A-linked aldehyde dehydrogenase (Rudolph et al., 
1968). It involves varying one substrate while holding the other two at a 
fixed level in the general concentration range of their Michael is constants. 
This experiment is then repeated, but at different concentrations of the 
fixed substrates, maintaining the ratio of the concentrations of the two 
fixed substrates constant. The other two substrates are then varied as 
described for the first one, making a total of three experiments necessary 
to determine if the mechanism is sequential or ping-pong. 
The possible mechanisms for three substrate enzymes assuming analogy 
with observed two substrate mechanisms are summarized in Appendix I. These 
equations have been presented elsewhere (Fron®, 1957, Dalziel, 1969) and are 
included here for convenient reference. The patterns of the initial rate 
experiments for tne individual mechanisms are shown in Table 2. With 
sequential mechanisms, whether ordered, partially ordered, or random 
(Mechanisms I to V), the lines on the Lineweaver-Burk (1934) plots all 
intersect either on or to the left of the 1/v axis. For a ping-pong type 
mechanism (Mechanisms VI to X), one or more of the three sets of data 
should yield parallel lines on the reciprocal plots. 
The reciprocal plots from the initial rate study of adenylosuccinate 
synthetase are shown in Figures 3, 4, and 5. The lines all intersect to 
the left of the l/y axis, thus eliminating all ping-pong mechanisms from 
further consideration. Mechanism III in which substrates A and B can add 
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Table 2. Initial rate patterns for the various three substrate 
mechanisms^ 
Mechanism^ 
Plot 
1/A 1/B 1/C 
I I^ I I 
II I I I 
III I I o
 Q
. 
IV I I I 
V I I I 
VI P® P 
VII I I P 
VIII P I I 
IX I I P 
X P I I 
^Based on the experimental protocol described by Fromm (1967). 
The numbers refer to the mechanisms listed in Appendix I. 
^I refers to a Lineweaver-Burk (1934) plot in which the lines 
intersect to the left of the 1/y axis. 
^0 refers to a Lineweaver-Burk (1934) plot in which the lines 
intersect on the 1/u axis. 
refers to a Lineweaver-Burk (1934) plot in which the lines are 
parallel. 
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(l/IMP)xlO-4M 
Figure 3. Plot of reciprocal of initial reaction velocity (v) with 
respect to the reciprocal of the molar concentration of IMP 
The respective concentrations of aspartate and GTP were: 
• . 0.31 and 0.0244 mM V, 0.42 and 0.0325 mM 
o , 0.62 and 0.0487 mM X , 1.25 and 0.0975 mM. 
The IMP concentration was varied from 17.8 to 143.0 pM. 
Other experimental details are described under "Experimental 
Procedure". 
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(1/GTP) X 10-4% 
Figure 4. Plot of reciprocal of initial reaction velocity (v) with 
respect to the reciprocal of the molar concentration of GTP 
The respective concentrations of aspartate and IMP were: 
• , 0.42 and 0.050 mM O , 0.62 and 0.075 mM 
X , 1,25 and 0.150 mM. 
The GTP concentration was varied from 8.1 to 65.0 pM. 
Other experimental details are described under "Experimental 
Procedure". 
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l/ASPARTATE) X lO'^M 
Figure 5. Plot of reciprocal of initial reaction velocity (v) with 
respect to the reciprocal of the molar concentration of 
aspartate 
The respective concentrations of GTP and IMP were: 
•, 0.027 and 0.0375 mM V, 0.037 and 0.050 mM 
o, 0.054 and 0.075 mM X, 0.109 and 0.150 mM. 
The aspartate concentration was varied from 0,12 and 1.31 mM. 
Other experimental details are described under "Experimental 
Procedure". 
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randomly to the enzyme and substrate C is the obligatory third substrate 
is also eliminated since none of the plots converge on the 1/y axis. 
Some further information can be obtained from the initial rate 
experiments. The slopes and intercepts of the initial rate reciprocal 
plots can be replotted against the reciprocal of the concentration of one 
of the other substrates. The expected replots for the various mechanisms 
are given in Table 3. For the sequential mechanisms, the rate equations 
for Mechanisms III, IV, and V predict that one or more of the slope replots 
will intersect the origin. When the data from Figures 3, 4, and 5 were 
treated in this manner, all replots had nonzero intercepts on the vertical 
axis. Thus, the initial rate data exclude all mechanisms except Mechanisms 
I and II. 
Competitive inhibition studies 
It has been suggested (Fromm, 1967) that a choice may be made among the 
various three-substrate mechanisms by use of competitive inhibitors. The 
following experiments were undertaken to distinguish between the possible 
sequential mechanisms. 
Succinate was found to be a competitive inhibitor of aspartate as 
shown in Figure 6. Figures 7 and 8 show that succinate is a noncompetitive 
inhibitor with respect to both IMP and GTP. 
Hampton (1960) has reported the inhibition of adenylosuccinate 
synthetase by thio-IMP and it has been shown to inhibit the enzyme from 
other sources (Atkinson et al. ^ 1964; Salser et al. y 1960). Ths binding of 
this compound to the enzyme has been studied by Baker and Tanna (1965a, c) 
and it was shown to be an effective inhibitor at relatively low 
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Table 3. Graphical method for differentiating between various three-
substrate mechanisms® 
, Substrate A Substrate B Substrate C 
Mechanism 
Slope Intercept Slope Intercept Slope Intercept 
I N N N N 
II N N N N N N 
III NO^ N NO N N A 
IV NO N N L N L 
V N N NO L N N 
VI L L L L L L 
VII L L L L L N 
VIII L N L L L L 
IX L L L L L N 
X L N L L L L 
The normal Lineweaver-Burk (1934) plots for each substrate are 
made by the procedure described by Fromm (1967) and the slopes and 
intercepts for the different fixed concentrations are determined and 
then plotted against the reciprocal of one of the fixed concentrations. 
'^The numbers refer to the mechanisms listed in Appendix I. 
refers to nonlinear replots with nonzero intercepts on the 
y axis. 
refers to linear replots with nonzero intercepts on the y axis. 
^NO refers to nonlinear replots which intersect the origin. 
^A refers to a case which the reciprocal plot intersects on the axis. 
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Figure 6. Plot of reciprocal of initial reaction velocity (v) with 
respect to the reciprocal of the molar concentration of 
aspartate in the presence and absence of succinate 
GTP and IMP concentrations were held constant at 0.033 and 
0.15 mM respectively, and aspartate was varied from 0.208 to 
1.67 mM. Succinate concentrations were none (X), 10 (o), 
and 20 mM (•). Other experimental details are described under 
"Experimental Procedure". 
2 3  4  
(l/ASPARTATE) X lOT^M 
24 
(l/IMP) X I0'4 M 
Figure 7. Plot of reciprocal of initial reaction velocity (v) with 
respect to the reciprocal of the molar concentration of 
IMP in the presence and absence of succinate 
GTP and aspartate concentrations were held constant at 0.033 
and 0.375 mM respectively, and IMP was varied from 0.019 to 
0.15 mM. Succinate concentrations were none (X), 10 (o), 
and 20 mM (•). Other experimental details are described 
under "Experimental Procedure". 
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Figure 8. Plot of reciprocal of initial reaction velocity (v) with 
respect to the reciprocal of the molar concentration of GTP 
in the presence and absence of succinate 
IMP and aspartate concentrations were held constant at 0.15 
and 1.0 mM respectively, and GTP was varied from 0.012 to 
0.095 mM. Succinate concentrations were none (X), 12.5 (O), 
25 (V), and 50 mM (•). Other experimental details are 
described under "Experimental Procedure". 
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concentrations. The effect of thio-IMP with respect to IMP is shown in 
Figure 9. The data clearly indicate that it is a competitive inhibitor of 
IMP. Figures 10 and 11 show that thio-IMP is a noncompetitive inhibitor 
with respect to both GTP and aspartate. 
The enzyme seemed to be insensitive to inhibition by most nonguanyl 
nucleotide di- and triphosphates (Wyngaarden and Greenland, 1963), and the 
use of monophosphates as inhibitors of GTP presented the problem of possible 
binding to the IMP site. Because of this, the B, y-methylene diphosphonate-
substituted derivative of GTP, guanylyl methylene diphosphonate, which is 
not a substrate for the reaction, was tested as an inhibitor of GTP. Figure 
12 indicates that it is a competitive inhibitor for GTP. The inhibition 
relative to IMP and aspartate was once again noncompetitive as shown in 
Figures 13 and 14. 
The rate equations for the effect of competitive inhibitors on the 
various mechanisms are shown in Appendix II along with the interactions of 
the inhibitor with the enzyme and the substrates. The predicted inhibition 
patterns for the various mechanisms are shown in Table 4. 
The data for this enzyme show that a competitive inhibitor for a 
particular substrate will be noncompetitive relative to the other two 
substrates. As is shown in Table 4, only Mechanisms II and IV would give 
rise to this set of inhibition patterns. The data are totally incompatable 
with the ordered mechanism (Mechanism I) and Mechanism IV has been ruled 
out from the initial rate studies, so the competitive inhibition study 
supports the choice of the rapid-equilibrium fully random mechanism 
(Mechanism II) for adenylosuccinate synthetase. 
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Figure 9. Plot of reciprocal of initial reaction velocity (v) with 
respect to the reciprocal of the molar concentration of IMP 
in the presence and absence of thio-IMP 
Aspartate and GTP concentrations were held constant at 1.25 
and 0.048 mM respectively, and IMP was varied from 0.015 to 
0.136 mM. Thio-IMP concentrations were none (X), 0.012 (o), 
0.024 (V), and 0.048 mM (•). Other experimental details are 
described under "Experimental Procedure". 
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Figure 10. Plot of reciprocal of initial reaction velocity (v) with 
respect to the reciprocal of the molar concentration of GTP 
in the presence and absence of thio-IMP 
IMP and aspartate concentrations were held constant at 0.15 
and 5.0 mM respectively, and GTP was varied from 0.01 to 
0.09 mM. Thio-IMP concentrations were none (•), 0.019 (X), 
and 0.057 mM (o). Other experimental details are described 
under "Experimental Procedure". 
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Figure 11. Plot of reciprocal of initial reaction velocity (v) with 
respect to the reciprocal of the molar concentration of 
aspartate in the presence and absence of thio-IMP 
GTP and IMP concentrations were held constant at 0.095 and 
0.06 respectively, and aspartate was varied from 0.17 to 
1.56 mM. Thio-IMP concentrations were none (•), 0.014 (X), 
and 0.041 mM (o). Other experimental details are described 
under "Experimental Procedure". 
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(1/GTP) X ICT^M 
Figure 12. Plot of reciprocal of initial reaction velocity (v) with 
respect to the reciprocal of the molar concentration of 6TP 
in the presence and absence of G,Y-5'-guanylyl methylene 
diphosphonate 
IMP and aspartate concentrations were held constant at 0.15 
and 5.0 mM respectively, and GTP was varied from 0.012 to 
0.095 mM. 3,Y-5'-Guanylyl methylene diphosphanate concen­
trations were none (X), 0.031 (o), and 0.062 mM (•). Other 
experimental details are described under "Experimental 
Procedure". 
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Figure 13. Plot of reciprocal of initial reaction velocity (v) with 
respect to the reciprocal of the molar concentration of IMP 
in the presence and absence of 8,y-5'-guanylyl methylene 
diphosphonate 
Aspartate and GTP concentrations were held constant at 5.0 
» 
and 0.047 mM respectively, and IMP was varied from 0.012 to 
0.10 mM. 3,y-5'-Guanylyl methylene diphosphonate concen­
trations were none (•), 0.083 (X), and 0.166 mM (o). Other 
experimental details ?re described under "Experimental 
Procedure". 
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Figure 14. Plot of reciprocal of initial reaction velocity (v) with 
respect to the reciprocal of the molar concentration of 
aspartate in the presence and absence of &,y-5'-guanylyl 
methylene diphosphonate 
GTP and IMP concentrations were held constant at 0.095 and 
0.15 mM respectively, and aspartate was varied from 0.31 to 
2.5 mM. B,y-5'-Guanylyl methylene diphosphonate concen­
trations were none (•), 0.031 (X), and 0.062 mM (o). Other 
experimental details are described under "Experimental 
Procedure". 
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Table 4. Competitive inhibition patterns for various three-substrate 
mechanisms^ 
Mechanism^ 
Competitive 
inhibitor for 
substrate 
1/A 
plot 
1/B 
plot 
1/C 
plot 
A C^ Nd.e 
I B uf C N9 
G u U C 
A c N N 
II B N C N 
C N N C 
A C N Ch 
III B N G C^ 
C U U C 
A c N N 
IV B u C N 
C u N C 
®The various interactions of the competitive inhibitor is given in 
Appendix II along with the inhibited rate equation. 
'^The numbers refer to the mechanisms listed in Appendices I and II. 
refers to a Lineweaver-Burk (1934) plot which shows competitive 
inhibition. 
refers to a Lineweaver-Burk (1934) plot which shows noncompetitive 
inhibition. 
®If EI reacts with B to form EIB, the plots would be nonlinear. 
refers to a Lineweaver-Burk (1934) plot which shows uncompetitive 
inhibition. 
^If EAI reacts with C to form EAIC, the plot would be nonlinear. 
If EIB reacts with C to form EIBC, the plot would noncompetitive. 
^If EIA reacts with C to form EIAC, the plot would be noncompetitive. 
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Table 4. (Continued) 
Competitive 1/A 1/B 1/C 
Mechanism inhibitor for plot plot plot 
substrate 
A C N N 
V B N C N 
C N N C 
A C U U 
VI B U C U 
C u u C 
A c NJ U 
VII B u C U 
C u u C 
A c u U 
VIII B u c [^k 
C u u C 
A c N U 
IX B N c U 
C U u C 
A C u U 
X B u c N 
C u N C 
^If EI reacts with B to form EIB, the plot would be nonlinear. 
"^If E'l reacts with C to form E'lC , the plot would be nonlinear. 
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Product inhibition studies 
Further confirmation of the conclusions reached from the competitive 
inhibition study was obtained from a product inhibition study. If the 
possible abortive complexes are considered, analogous to the complexes 
formed in the competitive inhibition study, the rate equations for 
Mechanism II with a product present are the same as derived for competitive 
inhibition with P, Q, or R substituting for I. Thus, if the product binds 
at only one site, the same patterns should be observed with the product 
inhibitors as were observed with the competitive inhibitors. Because 
adenylosuccinate is derived from both IMP and aspartate, it seemed 
probable that it could bind at more than one site, causing a change in the 
type of inhibition observed. The product inhibition patterns for adenylo­
succinate are shown in Figures 15, 16, and 17. Since it is competitive for 
IMP and noncompetitive relative to aspartate and GTP, apparently the 
adenylosuccinate binds significantly only to the IMP site and aspartate 
can bind even in the presence of adenylosuccinate indicating that the two 
sites may be spatially separated. 
The effect of GDP with respect to the three substrates was also 
studied and the data is shown in Figures 13, 19, and 20. It was found to 
be competitive with GTP and noncompetitive relative to the other two 
substrates. The effects of these two products are in agreement with the 
conclusions reached from the competitive inhibition experiments. 
Inhibition with Pi was studied relative to GTP and it was found to be 
noncompetitive with respect to GTP. The concentration required for signifi­
cant inhibition (10 mM Pi), along with its probable binding at the IMP site 
at these high concentrations, weaken any conclusions that might be drawn 
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0 2 3  
(I/IMP) X 10"^ M 
Figure 15. Plot of reciprocal of initial reaction velocity (v) with 
respect to the reciprocal of the molar concentration of IMP 
in the presence and absence of adenylosuccinate 
GTP and aspartate concentrations were held constant at 0.057 
and 2.5 mM respectively, and IMP was varied from 0.03 to 
0.15 mM. Adenylosuccinate concentrations were none (X), 
0.011 (o), 0.023 (V), and 0.045 mM (•). Other experimental 
details are described under "Experimental Procedure". 
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0  1 2  3  
(l/ASPARTATE) X 10"^ M 
Figure 16. Plot of reciprocal of initial reaction velocity (v) with 
respect to the reciprocal of the molar concentration of 
aspartate in the presence and absence of adenylosuccinate 
GTP and IMP concentrations were held constant at 0.057 and 
0.060 mM respectively, and aspartate was varied from 0.31 to 
1.56 mM. Adenylosuccinate concentrations were none (X), 
0.008 (o), and 0.023 mM (o). Other experimental details are 
described under "Experimental Procedure". 
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Figure 17. Plot of reciprocal of initial reaction velocity (v) with 
respect to the reciprocal of the molar concentration of GTP 
in the presence and absence of adenylosuccinate 
IMP and aspartate concentrations were held constant at 0.06 
and 1.25 mM respectively, and GTP was varied from 0.014 to 
0.114 mM. Adenylosuccinate concentrations were none (•), 
0.014 (X), and 0.034 mM (o). Other experimental details 
are described under "Experimental Procedure". 
39 
b 
X 
> 
2 5  0 3  4  
(1/GTP) X lO'^M 
Figure 18. Plot of reciprocal of initial reaction velocity (v) with 
respect to the reciprocal of the molar concentration of GTP 
in the presence and absence of GDP 
Aspartate and IMP concentrations were held constant at 2.5 
and 0.04 tnM respectively, and GTP was varied from 0.023 to 
0.114 mM. GDP concentrations were none (X), 0.015 (o), 0.030 
(V), and 0.061 mM (•). Other experimental details are 
described under "Experimental Procedure". 
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Figure 19. Plot of reciprocal of initial reaction velocity (v) with 
respect to the reciprocal of the molar concentration of IMP 
in the presence and absence of GDP 
Aspartate and GTP concentrations were held constant at 2.5 
and 0.057 mM respectively, and the IMP was varied from 0.015 
to 0.12 mM. GDP concentrations were none (•), 0.023 (X), and 
0.046 mM (o). Other experimental details are described under 
"Experimental Procedure". 
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Figure 2v .  Plot of reciprocal of initial reaction velocity (v) with 
respect to the reciprocal of the molar concentration of 
aspartate in the presence and absence of GDP 
GTP and IMP concentrations were held constant at 0.15 and 
0.057 mM respectively, and aspartate was varied from 0.31 to 
2.50 mM. GDP concentrations were none (•), 0.018 (X), and 
0.037 mM (o). Other experimental details are described under 
"Experimental Procedure". 
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from these experiments. The problem encountered with the Pi inhibition 
study indicates the value of the competitive inhibition approach. 
Determination of kinetic constants 
It was not possible to determine values for the inhibition constants 
from the data above because of the obvious complexity of the rate equations. 
Apparent inhibition constants were calculated as shown in Table 5. A 
summary of the inhibition studies is also shown in Table 5. 
Determination of Michael is constants from the initial rate data is 
complicated by the fact that a (substrate)^ term occurs in the denominator 
of some of the equations derived from the initial rate equations which are 
used for the slope and intercept replots. In the case of the rapid 
equilibrium, fully random mechanism (Mechanism II), for example, when a 1/A 
experiment is performed, the slope term will be 01 + P^/C + 05/xC + gy/xC^ 
and the intercept term will be 0^ + 02/xC + 03/C +057x0^, since B = xC 
where x is a constant for the particular experiment. Both equations 
describe a parabolic behavior for the replot. In order to determine the 
Km values, an extrapolation to infinite substrate concentration is made and 
0Q/EQ and ^substrate^^o determined and the Km for a particular 
substrate is calculated from Pgubstrate'^^o* Michael is constants were 
calculated to be: 6TP, 1 x lO"^ M; IMP, 2 x 10"^ M; and aspartate, 3.5 
10-4 M. . 
Table 5. Inhibition of adenylosuccinate synthetase by competitive and product inhibitors 
Inhibitor 
Type of inhibition relative to 
Aspartate GTP IMP 
Apparent 
inhibi tion 
constant® 
Succinate 
Thio-IMP 
e-Y-5'-Guanylyl 
methylene 
diphosphonate 
GDP 
Adenylosuccinate 
Competitive Noncompetitive 
Noncompetitive Noncompetitive 
Noncompetitive Competitive 
Noncompetitive 
Competi tive 
Noncompetitive 
Noncompetitive Competitive Noncompetitive 
Noncompetitive Noncompetitive Competitive 
7.5 mM 
10 yM 
80 uM 
12 uM 
5 ijM 
Calculated from the equation = (I)S^/(St-S„) where K. is the apparent inhibition 
^ app \ ' 0 I 0 app rr 
constant, I is the concentration of the inhibitor, S is the slope of the uninhibited line 
from the competitive inhibition plot, and S, is the slope of the inhibited line on the same 
graph for a particular I. 
The equation is derived by combining the slope terms of the reciprocal plots for the 
inhibited and uninhibited Michaelis-Menten equations as follows: 
Sj = (Km/Vm)(l + (O/K^^pp) and = Km/Vm 
= Sod + (i)/%p) 
^app = - V 
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GENERAL DISCUSSION 
The purification of adenylosuccinate synthetase presented in this 
study represents a significant improvement over previous reported 
preparations. Hopefully, physical and chemical studies can be carried out 
on the protein to determine more of its properties. 
The kinetic experiments described in this study serve to verify the 
usefulness of studying the kinetic mechanisms of three-substrate enzyme 
systems by use of competitive inhibitors of substrates. These investi­
gations, when combined with the initial rate findings for Coenzyme A-1inked 
aldehyde dehydrogenase (Rudolph et al. , 1968) indicate that a choice can be 
readily made between ping-pong and sequential mechanisms by use of the 
experimental protocol outlined above. In the case of adenylosuccinate 
synthetase, it is clear that only one pathway of enzyme and substrate 
interaction is consistent with the experimental results, i.e. the fully 
random mechanism (Mechanism II) which is depicted in Scheme I. 
A'. 
EPn-A E A B C  E P Q J i  
E Q R  ^  E R  
E  
The replotting technique used to differentiate between the various 
sequential mechanisms may prove to be of general value for distinguishing 
between different sequential mechanisms for three substrate systems. As 
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Table III indicates, no additional information can be obtained in the case 
of ping-pong mechanisms using this procedure; however, each sequential 
mechanism considered has a unique replot pattern. The nonlinearity of some 
of the replots is caused by varying both of the fixed substrates in a 
constant ratio as described for the determination of the Michael is constants. 
It may be necessary to vary the fixed substrates over a wide concentration 
range in order to determine whether a replot is truly linear or nonlinear. 
The experimental difficulty inherent in this procedure will be a function 
of the rate constants of the system. Therefore, it is felt that evidence 
for a given mechanism which is obtained by the replotting procedure 
outlined here should be tested using the approach involving competitive 
substrate inhibitors and, if possible, product inhibitors. 
The mechanisms of enzymic reactions that involve synthesis of amide 
bonds have been extensively investigated in recent years (Hartman and 
Buchanan, 1958; Miller and Buchanan, 1962; Krishnaswamy et al. y 1962; Snoke 
and Bloch, 1955; and Mizobuchi et al., 1968). Reactions similar to the one 
descr ibed in  th is  s tudy inc lude g lu tamine synthetase (Kr ishnaswamy e t  a l .  ^  
1962), glutathione synthetase (Snoke and Bloch, 1955), and a number of 
enzymes involved in the biosynthesis of purines (Buchanan and Hartman, 
1959). All these cases involve the cleavage of a nucleoside triphosphate 
to a diphosphate and inorganic phosphate. 
Two general types of interactions for this class of enzymes have been 
proposed. Krishnaswamy et al. y (1962) suggested the formation of a 
phosphorylated intermediate in the glutamine synthetase reaction and have 
since presented evidence for this proposal including the ability of B-
aminoglutaryl phosphate to react with ADP to form 3-aminoglutarate 
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(Khedouri et  a l .  y 1964) and ATP as well as the isolation of a phos-
phorylated methionine sulfoxide derivative (Ronzio and Meister, 1968). 
Lieberman (1956) also suggested the possibility of 6-phosphoryl-IMP as an 
intermediate in adenylosuccinate synthesis from the fact that 6-^®0-IMP 
gives rise to ^^O-labelled phosphate. Hartman and Buchanan (1958) and 
Graves and Boyer (1962), on the other hand, have proposed that for adenylo­
succinate synthetase and other enzymes, all three substrates interact at 
the enzyme surface in a concerted fashion without formation of new covalent-
1 inked compounds as obligatory intermediates. This suggestion is based on 
the observation that all three products are required to obtain reversal of 
the reaction and no partial reactions are observed even with arsenate 
replacing phosphate in the reaction (Miller and Buchanan, 1962). The 
absence of partial reactions does not necessarily exclude the formation of 
covalent intermediates since the requirement for GDP in the reverse 
reaction could be concerned with the formation of the proper protein 
conformation for reaction to occur. The mechanism proposed in this paper 
would be consistent with either idea and no further conclusions can be 
drawn without a detailed study of the catalytic steps of the reaction. 
The exclusion of ping-pong mechanisms from consideration would rule 
out the type of mechanism that has been considered for glutamine synthetase 
assuming release of products after formation of covalent intermediates. 
However, if no products were released until all substrates were present on 
the enzyme surface, the random mechanism would not be inconsistent with 
this idea. 
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APPENDIX I 
Mechanisms and Rate Equations for Enzyme Systems Utilizing 
Three Substrates 
The shorthand notation of Cleland (1963) is used in describing these 
mechanisms and the rate equations are given in terms of 0's as suggested 
by Dalziel (1957). These rate equations have appeared elsewhere (Fromm, 
1967; Dalziel s 1969) but are included here for clarity. 
Quaternary complex mechanisms 
I. Ordered Ter Ter 
A B C  P  Q  R  
I 1^2 ka I kg I kg ky | kg kg j k^p k^ | k^a . 
E EA EAB (EABC) EQR ER E 
The rate equation for this mechanism is: 
E^/y  =  0Q +  0 i /A +  02/B +  03/C +  04 / (A) (B)  +  05 / (6 ) (C)  +  06 / (A) (B) (C) .  
(2 )  
EQ represents total enzyme concentration and y, initial velocity. A, B, 
and C represent substrates and R, Q, and P are taken to be their respective 
products. These definitions apply to all the mechanisms depicted here. 
The 0 values are defined as: 
0Q -  l / ky  +  1 / kg  +  1 / k i i ,  01  =  1 / k i ,  02  =  l / kg ,  03  =  ( kg  +  kT^ /kgky ,  
04 ~ k2/kik3, 05 = kij(k5 + k7)/k3k5k?, 0g = k2k4(kg + k7)/kik3k5k7 
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II. Random Ter Ter (Rapid Equilibrium) In this and all rapid 
equilibrium mechanisms included here, it is assumed that all steps in the 
sequence which are in equilibrium (steps that are represented by K's) 
equilibrate rapidly relative to the rate limiting step. 
E + A = EA, Ki EC + B = EBC, K5 EB + C = EGA, Kg 
E + B = EB, Kg EB + A = EAB, Kg EAB + C = EABC, K^q 
E + C = EC, K3 EC + A = EAC, Ky EAC + B = EABC, K^ 
EA + B = EAB, K^ EA + C = EAC, Kg EBC + A = EABC, K^g 
•1 
EABC ^ EPQR 
^2 
All equilibria occurring after the formation of EPQR are omitted 
since they are not kinetically significant. This mechanism is depicted 
in Scheme I in the General Discussion. 
The rate equation for this mechanism is: 
Ep/y = + 0i/A + 02/B + 03/C + 0^/(A)(B) + 05/(A)(C) + 05/(8)(C) + 
07/(A)(B)(C). (3) 
where 
0Q = 1/ki, 012" ^12/^1, 02 = Kii/kg, 03 = Kio/ki, 04 = KgKi2/ki, 
05 = KyKii/ki, 00 = KgKii/ki, 07 = KiKgKii/ki 
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III. Random AB (Rapid Equilibrium) 
I 
K. 
P 
tK, 
EAB (EABC) ki (EPQR) EQR 
The rate equation for this mechanism is: 
01 02 03 04 
+ + 
" ' ^ C * (A)(C) (B)(C) (A)(B)(C) 
where 
Ks K4K5 K3K5 K1K3K5 
^0 kT ' kT ' ^2 ^ "TT" ' ^ 3 - -TT" ' ~ 
IV. Random BC (Rapid Equilibrium) 
B C 
'' Ki 
^ \ 
E EA \ 
Y 
kl 
K; 
Q 
1k 
cnn 
ERR 
TT~ 
8 A K 
(EABC) (EPQR) 
Kg j Kg 
C B 
10 
ER E 
The rate equation for this mechanism is : 
01 02 03 01 
IT = *0 + TT + IT + TBTTCT (A)(B)(C) 
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where 
^0 ~ ¥ ' 01 ~ T7~ » 02 - — » 03 ~ 
' - ki 
, 014 = 
KiKzKij 
V. Random AC (Rapid Equilibrium) 
A B C  
i^l Kg I Kg 
EA EAB 
P Q R 
fK? f Kg fKii 
E \ / (EABC) k2 (EPQR) 
IK? K14 j Kg 
C B A 
EQR ER 
EPQ EP 
Kg . . Kio ' 1 2  
R Q P 
The rate equation for this mechanism is: 
Eq 01 02 03 04 05 
IT = 9o + TT + IT + wm * wm * (A)(B)(c) 
where 
( 6 )  
K.K 4^6 KqK 31^5 
^0 ~ "ki » 01 " ~ » 02 - FT » 03 — ' 04 * 05 -
K1K3K5 
ki '  ^ 2 ki " ki 
Pinq-Ponq mechanisms 
VI. Hexa Uni Ping-Pong 
A P B 
J / \ / 
ki , , k2 kg k4 kg ^ , ke ky ks kg ^ ^  kio kii ki2 
E (EA) E' (E'B) 
The rate equation for this mechanism is: 
E" E"C 
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where 
, , , (kz+kg) (kg+k-/) 'kio+kn) 
Co ° k; + ^ iTTT ' = -k^ • ' -T^  ' "3 = k,k,, 
VII. Ordered Bi Uni Uni Bi Pinq-Ponq 
A B PC Q R 
/ / V / V 
ki ^ ka kg k4 kg ke ky œ 0
0 kio kii ki2 
> 
' \ / \ / 
E EA (EAB) E' (E'C) ER E 
The rate equation for this mechanism is: 
E 01 02 03 04 
— = 00 +X=~B"'"r"TÂÏÏBT (8) 
where 
1 1 1  1  (k^+kg) (kg+kg) 
®0 = kl ^  k7 kTT > «"i " kT • "2 = . 
kzfkt+ks) 
"•> ' kiksks 
VIII. Ordered Uni Uni Bi Bi Pinq-Ponq 
A P B C Q 
J < 1 ' 
\ > » 
f kz kg k4 kg ^ ^ ke ky ^ kg kg kio kii ki2 
Ë ËÂ r ÊB ËBC ER~ I 
The rate equation for this mechanism is: 
Eg 01 02 03 0 4 
— TBTTCT 
where 
1 1 1  ( k ^ + k g )  1 (kg+kg) 
"o ° '•¥?'• ÏÏ77 • = k.k; .  02 = ki- .  Us = k7kg '  
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" kgkykg 
IX. Random Bi Uni Uni Bi Pinq-Pong 
A B 
(EAB) 
The rate equation for this mechanism is: 
01 02 03 04 
= WÎbT '0 „ t ^ ^— (10) 
where 
Kit K3 (kg+kg) K1K3 
®0 ° k7 ktr ' ° k7 • ° kj • ° ' ®'' ° ks 
X. Random Uni Uni Bi 81 Pinq-Pong 
B C 
(E'BC) 
C B 
The rate equation for this mechanism is: 
Eq 01 02 03 0 k 
IT = "0 X T T TBTTCT 
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where 
] 1 1 
Co = kT + r; + k: - C' = -w 
58 
APPENDIX II 
Rate Equations Describing the Effect of Competitive Inhibitors 
on the Three-Substrate Mechanisms of Appendix ^ 
The equations describing the effects of competitive inhibitors on 
Mechanisms I, II, IV, V, and VII have been presented by Froirm (1967) and, 
although they are summarized in Table IV, will not be presented here. The 
inhibited rate equations for Mechanisms III, VI, VIII, IX, and X are 
presented below. The 0's are the same as defined in Appendix I, and the 
assumed additional interactions in the presence of the inhibitors are 
given with each equation. The competitive inhibitor, I, is assumed to 
Interact at the same enzymatic site as does the substrate it is competitive 
wi th. 
III. Random AB (Rapid Equilibrium) 
A. Inhibitor for A: 
E + I = EI K. 
EI + B = EIB 
EB + I = EIB K... 
EIB + C = EIBC K-y 
-) 03 
"TBTOT 
04 
(A)(B)(C) (12) 
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B. Inhibitor for B: 
E + I = EI K. 
EI + A = EIA K^. 
EA + I = EIA 
EAI + C = EAIC K.y 
E_ 01 02 03 (I) (I)(C) "X 
0 = 0  +  —  +  +  (  1  +  
V  0  C (A){C) (B)(C) V K-ii K-n -IV yii^iv J 
04 /" (I)' , 
1  +  (13 )  
(A)(B)(C) V K. 
C. Inhibitor for C: 
EAB + I = EABI 
Eq 01 / I\ 02 03 04 
—  - 0 Q +  —  ( l  +  —  ) +  +  +  ( 1 4 )  
c V K.y (A)(c) (B)(C) (A)(B)(C) 
IV. Hexa Uni Ping-Ping 
A. Inhibitor for A: 
E + I = EI Ki 
TT - 0. + f 1 + ) + + (15) 
"  ° A \ K i / B  C  
B. Inhibitor for B: 
E' + I = E'l Ki 
Eo ^ 01 02//' (iy\ 03 , , 
— = 0Q +  — + —( 1 + — )+ — (16)  
"  ° A  B \ K i / C  
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C. Inhibitor for C: 
E" + I = E" I Kj 
E .  „  0 1  0 2  0 3 /  ( I )  
=  0  f  -r  
A B C \ Kl 
°  " • -  ~  +  —f  1  +  — ]  (17 )  
VIII. Ordered Uni Uni Bi Bi Ping-Pong 
A. Inhibitor for A: 
E + I = El Kl 
E.  01  /  ( I ) \  02  03  04  
— = 0 + — { T + ) + — + — + (18) 
" ° A \ Kl / B C (B)(C) 
B. Inhibitor for B: 
E' + I = E'I Kl 
E'I + C = E'IC Kg 
E„ 01  02  /  (I )  ( I ) (C) \  03  
f  = 0 .  +  - + I 1 + —— + j + 
A B \ Kl KiKg / C 
04  /  ^ ( I )  ^  ( I ) {C) \  
(B)(C) \ Kl KiKz J 
0 A B C \ Kl / (B)(C) 
(19 )  
C. Inhibitor for C: 
E'B + C = E'BC Kl 
Eo 01  02  /  <I ) \  04  
— = 0 + — + — + — f 1 + J + (20) 
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IX. Random Bi Uni Uni Bi Pinq-Ponq 
A. Inhibitor for A: 
E + I = EI K. 
EI + B = EIB K.. 
EB + I = EIB K... 
+  — ^ 1 + - ^  ( 2 1 ,  
" 0 A \ K,.,/ B C (A)(B) K. / 
B. Inhibitor for B: 
E + I = EI K. 
EA + I = EIA K-. 
EI A - EIA K... 
(22) 
^ ° A B \ K../ C (A)(B) \ K. 
C. Inhibitor for C: 
E' + I = E'l K, 
! o . 0  ( 2 3 ,  
° A B C V K. / (A)(B) 
X. Random Uni Uni Bi Bi Pinq-Ponq 
A. Inhibitor for A: 
E + I = EI K. 
+ (24, 
° A V K. / B C (B)(C) 
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Inhibitor for B: 
E' + I = F'l 
E'C + I = E'lC K.. 
E'l + C = E'lC K... 
01 02 / (I)\ 03 0» / (I) , , , 
+  — +  — I 1  +  I  +  — + (  1  +  )  ( 25 )  
A B \ K..y C (B){C) V X. 
Inhibitor for C: 
E' + I = E'l 
E'B + I = E'lB K.. 
E'l + B = E'lB K... 
02  03  /  (I ) '  
+ — + — ( 1 + (26) 
